"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome"

Eur J Dermatol. 2009 May-Jun;19(3):264-5. doi: 10.1684/ejd.2009.0630. Epub 2009 Feb 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Drug Carriers / administration & dosage*
  • Drug Carriers / adverse effects
  • Drug Eruptions / etiology
  • Drug Overdose
  • Foot Dermatoses / chemically induced*
  • Hand Dermatoses / chemically induced*
  • Humans
  • Paresthesia / chemically induced
  • Polyethylene Glycols / administration & dosage*
  • Polyethylene Glycols / adverse effects*
  • Syndrome

Substances

  • Antibiotics, Antineoplastic
  • Drug Carriers
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin